PhotoLegacy Pharmaceutical Packaging is recalling 40 repackaged lots of Losartan tablets, a prescription medication used to treat high blood pressure and congestive heart failure.

The product contains trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

Legacy has not received any reports of adverse events to date.

The following product, packaged in 30-count bottles, is being recalled:

LEGACY NDC#Name and StrengthCountLegacy Lot #Expiry
68645-577-54Losartan Potassium Tablets USP 25 mg3018095210/2019
68645-577-54Losartan Potassium Tablets USP 25 mg3018095312/2019
68645-577-54Losartan Potassium Tablets USP 25 mg3018108609/2019
68645-577-54Losartan Potassium Tablets USP 25 mg3018157201/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018092109/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018092210/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018092311/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018092411/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018111811/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018111910/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018140711/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018140812/2019
68645-578-54Losartan Potassium Tablets USP 50 mg3018157302/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018172502/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018172602/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018194803/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018196002/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018238503/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018238603/2020
68645-578-54Losartan Potassium Tablets USP 50 mg3018238703/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018088611/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018088712/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018088812/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018090512/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018112309/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018112410/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018112508/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018135111/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018135212/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018155111/2019
68645-579-54Losartan Potassium Tablets USP 100 mg3018162806/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018162906/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018172706/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018172806/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018189003/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018189106/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018189706/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018211403/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018211906/2020
68645-579-54Losartan Potassium Tablets USP 100 mg3018212006/2020
 

The recalled product, which can be identified by checking the product name and repackaged lot number on the bottle, was distributed by pharmacies nationwide.

What to do

Patients who have the recalled product should return it to the dispensing pharmacy.

Consumers with questions regarding this recall should contact their dispensing pharmacy during normal business hours or their physician or healthcare provider if they have had any problems related to taking or using the product.

What would happen if you fell down?

A medical alert system can help. Read our guide to learn more.


    Share your Comments